全文获取类型
收费全文 | 2131篇 |
免费 | 216篇 |
国内免费 | 2篇 |
出版年
2023年 | 12篇 |
2022年 | 29篇 |
2021年 | 59篇 |
2020年 | 25篇 |
2019年 | 30篇 |
2018年 | 49篇 |
2017年 | 36篇 |
2016年 | 75篇 |
2015年 | 113篇 |
2014年 | 98篇 |
2013年 | 131篇 |
2012年 | 185篇 |
2011年 | 170篇 |
2010年 | 116篇 |
2009年 | 89篇 |
2008年 | 135篇 |
2007年 | 137篇 |
2006年 | 137篇 |
2005年 | 100篇 |
2004年 | 105篇 |
2003年 | 88篇 |
2002年 | 82篇 |
2001年 | 28篇 |
2000年 | 27篇 |
1999年 | 30篇 |
1998年 | 23篇 |
1997年 | 10篇 |
1996年 | 15篇 |
1995年 | 10篇 |
1994年 | 16篇 |
1993年 | 14篇 |
1992年 | 18篇 |
1991年 | 10篇 |
1990年 | 14篇 |
1989年 | 13篇 |
1988年 | 10篇 |
1987年 | 11篇 |
1986年 | 10篇 |
1985年 | 9篇 |
1984年 | 4篇 |
1983年 | 7篇 |
1982年 | 6篇 |
1981年 | 5篇 |
1979年 | 8篇 |
1978年 | 14篇 |
1977年 | 3篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 3篇 |
1967年 | 3篇 |
排序方式: 共有2349条查询结果,搜索用时 15 毫秒
141.
Benoit Visseaux Charlotte Charpentier Gilles Collin Mélanie Bertine Gilles Peytavin Florence Damond Sophie Matheron Eric Lefebvre Fran?oise Brun-Vézinet Diane Descamps ANRS CO HIV- Cohort 《PloS one》2015,10(8)
Background
Maraviroc activity against HIV-2, a virus naturally resistant to different HIV-1 antiretroviral drugs, has been recently demonstrated. The aim of this study was to assess HIV-2 susceptibility to cenicriviroc, a novel, once-daily, dual CCR5 and CCR2 antagonist that has completed Phase 2b development in HIV-1 infection.Methods
Cenicriviroc phenotypic activity has been tested using a PBMC phenotypic susceptibility assay against four R5-, one X4- and one dual-tropic HIV-2 clinical primary isolates. All isolates were obtained by co-cultivation of PHA-activated PBMC from distinct HIV-2-infected CCR5-antagonist-naïve patients included in the French HIV-2 cohort and were previously tested for maraviroc susceptibility using the same protocol. HIV-2 tropism was determined by phenotypic assay using Ghost(3) cell lines.Results
Regarding the 4 R5 HIV-2 clinical isolates tested, effective concentration 50% EC50 for cenicriviroc were 0.03, 0.33, 0.45 and 0.98 nM, similar to those observed with maraviroc: 1.13, 0.58, 0.48 and 0.68 nM, respectively. Maximum percentages of inhibition (MPI) of cenicriviroc were 94, 94, 93 and 98%, similar to those observed with maraviroc (93, 90, 82, 100%, respectively). The dual- and X4-tropic HIV-2 strains were resistant to cenicriviroc with EC50 >1000 nM and MPI at 33% and 4%, respectively.Conclusions
In this first study assessing HIV-2 susceptibility to cenicriviroc, we observed an in vitro activity against HIV-2 R5-tropic strains similar to that observed with maraviroc. Thus, cenicriviroc may offer a once-daily treatment opportunity in the limited therapeutic arsenal for HIV-2. Clinical studies are warranted. 相似文献142.
143.
Marianne Suter Paolo Salvioni Ramon F Thali Roland Scholz Kari Vaahtomeri Yolanda Auchli Helene Rechsteiner René A Brunisholz Benoit Viollet Tomi P Mäkelä Theo Wallimann Dietbert Neumann Wilhelm Krek 《The EMBO journal》2010,29(2):469-481
The mobilization of metabolic energy from adipocytes depends on a tightly regulated balance between hydrolysis and resynthesis of triacylglycerides (TAGs). Hydrolysis is stimulated by β‐adrenergic signalling to PKA that mediates phosphorylation of lipolytic enzymes, including hormone‐sensitive lipase (HSL). TAG resynthesis is associated with high‐energy consumption, which when inordinate, leads to increased AMPK activity that acts to restrain hydrolysis of TAGs by inhibiting PKA‐mediated activation of HSL. Here, we report that in primary mouse adipocytes, PKA associates with and phosphorylates AMPKα1 at Ser‐173 to impede threonine (Thr‐172) phosphorylation and thus activation of AMPKα1 by LKB1 in response to lipolytic signals. Activation of AMPKα1 by LKB1 is also blocked by PKA‐mediated phosphorylation of AMPKα1 in vitro. Functional analysis of an AMPKα1 species carrying a non‐phosphorylatable mutation at Ser‐173 revealed a critical function of this phosphorylation for efficient release of free fatty acids and glycerol in response to PKA‐activating signals. These results suggest a new mechanism of negative regulation of AMPK activity by PKA that is important for converting a lipolytic signal into an effective lipolytic response. 相似文献
144.
145.
Humans have developed a particular innate immunity system against African trypanosomes, and only two Trypanosoma brucei clones (T. b. gambiense, T. b. rhodesiense) can resist this defence and cause sleeping sickness. The main players of this immunity are the primate‐specific apolipoprotein L‐I (apoL1) and haptoglobin‐related protein (Hpr). These proteins are both associated with two serum complexes, a minor subfraction of HDLs and an IgM/apolipoprotein A‐I (apoA1) complex, respectively, termed trypanosome lytic factor (TLF) 1 and TLF2. Although the two complexes appear to lyse trypanosomes by the same mechanism, they enter the parasite through various modes of uptake. In case of TLF1 one uptake process was characterized. When released in the circulation, haemoglobin (Hb) binds to Hpr, hence to TLF1. In turn the TLF1–Hpr–Hb complex binds to the trypanosome haptoglobin (Hp)–Hb receptor, whose original function is to ensure haem uptake for optimal growth of the parasite. This binding triggers efficient uptake of TLF1 and subsequent trypanosome lysis. While Hpr is involved as TLF ligand, the lytic activity is due to apoL1, a Bcl‐2‐like pore‐forming protein. We discuss the in vivo relevance of this uptake pathway in the context of other potentially redundant delivery routes. 相似文献
146.
147.
148.
Cécile Frolet Meryam Beniazza Laure Roux Benoit Gallet Marjolaine Noirclerc-Savoye Thierry Vernet Anne Marie Di Guilmi 《BMC microbiology》2010,10(1):190
Background
Streptococcus pneumoniae is a widely distributed commensal Gram-positive bacteria of the upper respiratory tract. Pneumococcal colonization can progress to invasive disease, and thus become lethal, reason why antibiotics and vaccines are designed to limit the dramatic effects of the bacteria in such cases. As a consequence, pneumococcus has developed efficient antibiotic resistance, and the use of vaccines covering a limited number of serotypes such as Pneumovax® and Prevnar® results in the expansion of non-covered serotypes. Pneumococcal surface proteins represent challenging candidates for the development of new therapeutic targets against the bacteria. Despite the number of described virulence factors, we believe that the majority of them remain to be characterized. This is the reason why pneumococcus invasion processes are still largely unknown.Results
Availability of genome sequences facilitated the identification of pneumococcal surface proteins bearing characteristic motifs such as choline-binding proteins (Cbp) and peptidoglycan binding (LPXTG) proteins. We designed a medium throughput approach to systematically test for interactions between these pneumococcal surface proteins and host proteins (extracellular matrix proteins, circulating proteins or immunity related proteins). We cloned, expressed and purified 28 pneumococcal surface proteins. Interactions were tested in a solid phase assay, which led to the identification of 23 protein-protein interactions among which 20 are new.Conclusions
We conclude that whether peptidoglycan binding proteins do not appear to be major adhesins, most of the choline-binding proteins interact with host proteins (elastin and C reactive proteins are the major Cbp partners). These newly identified interactions open the way to a better understanding of host-pneumococcal interactions.149.
Jiu-Cun Wang Syeling Lai Xinjian Guo Xuefeng Zhang Benoit de Crombrugghe Sonali Sonnylal Frank C Arnett Xiaodong Zhou 《Arthritis research & therapy》2010,12(2):R60
Introduction
SPARC is a matricellular protein, which, along with other extracellular matrix components including collagens, is commonly over-expressed in fibrotic diseases. The purpose of this study was to examine whether inhibition of SPARC can regulate collagen expression in vitro and in vivo, and subsequently attenuate fibrotic stimulation by bleomycin in mouse skin and lungs. 相似文献150.
Gle Corine; Del Amo Yolanda; Bec Beatrice; Sautour Benoit; Froidefond Jean-Marie; Gohin Francis; Maurer Daniele; Plus Martin; Laborde Pierre; Chardy Pierre 《Journal of plankton research》2007,29(11):999-1014
Phytoplankton dynamics were assessed in the macrotidal ecosystemof Arcachon Bay through high-frequency surveys over a 5-yearperiod in order to characterize typology of environmental conditionsat the onset of the productive period. Temporal variations ofhydrological and biological parameters were examined in externaland internal waters of the lagoon, during the winter–springperiods from 1999 to 2003. An additional survey was performedduring winter–spring 2005 in order to study the verticalstructure of the water column. The occurrence of winter phytoplanktonblooms between January and March emerged as a recurrent event.The early onset of the productive period is influenced by thebiological functioning of adjacent Bay of Biscay oceanic waters.It is hypothesized that under a propitious hydrodynamic regime,phytoplankton inocula from the Bay of Biscay enter in the ArcachonBay where cells presumably find favourable conditions for theirfast development. The timing of the onset of those winter bloomsin Arcachon Bay seems to be mainly influenced by the presenceof anticyclonic weather conditions (associated with an increasein incident irradiance) during late winter (i.e. by February),while the water column does not show any particular stabilizationnor stratification liable to facilitate the onset of these blooms.Moreover, these winter blooms dominated by diatoms led to anearly nutrient depletion which could have inevitable consequenceson the structuration of the food web during spring and summer. 相似文献